Menu Back toWalking the Talk: What Happens When Clinical Trialists Join Clinical Trials?

DIA 2021 Global Annual Meeting


Walking the Talk: What Happens When Clinical Trialists Join Clinical Trials?

Session Chair(s)

Jane Elizabeth Myles, MS

Jane Elizabeth Myles, MS

  • Vice President, Clinical Trial Innovation
  • Curebase, United States
In this forum we share experiences as volunteers in Phase 3 COVID-19 vaccine trials. Few of us enroll in trials, even though our work is designing, executing, and analyzing clinical trials. This is a way to learn through our participation.
Learning Objective : Discuss stories of participating in a COVID-19 vaccine trial as a healthy volunteer; Evaluate insights on the patient experience in the trial, and the key takeaways as a clinical trialist that are made clear by participation; Identify potential options for a different patient experience in future trials that leverage technology and other patient-centric trial solutions.

Speaker(s)

Kelly Johnston McKee, MS

Panelist

Kelly Johnston McKee, MS

  • Vice President, Patient Recruitment and Registries
  • Medidata Solutions, United States
Angela  Radcliffe

Panelist

Angela Radcliffe

  • Head, Data Governance and Stewardship
  • Bristol-Myers Squibb Company , United States
Craig  Serra, MBA, MS

Panelist

Craig Serra, MBA, MS

  • Clinical Technology and Innovation
  • Novartis Pharmaceuticals Corporation, United States